TRLS — Trellus Health Share Price
Last trade - 00:00- £3.07m
- -£6.65m
- $0.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.2 | ||
| Price to Tang. Book | 0.33 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 202.1 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -34.89% | ||
| Return on Equity | -28.43% | ||
| Operating Margin | -35805.26% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 0.03 | 0.02 | 0.02 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Trellus Health plc is a United Kingdom-based digital health company. It offers a scientifically validated, personalized resilience-based self-management training program for people living with chronic conditions. It is focused on the intersection of chronic physical conditions and mental health. The Company’s approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, primarily focused on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and irritable bowel syndrome (IBS). The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Company’s wholly owned subsidiary is Trellus Health Inc.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 15th, 2020
- Public Since
- May 28th, 2021
- No. of Employees
- 31
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- London Stock Exchange
- Shares in Issue
- 161,508,333
- Address
- Avon House, 19 Stanwell Road, PENARTH, CF64 2EZ
- Web
- https://trellushealth.com/
- Phone
- Auditors
- Crowe U.K. LLP
Latest News for TRLS
Upcoming Events for TRLS
Trellus Health PLC Annual Shareholders Meeting
Half Year 2024 Trellus Health PLC Earnings Release
Similar to TRLS
1Spatial
London Stock Exchange
4Global
London Stock Exchange
Access Intelligence
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
FAQ
As of Today at 19:22 UTC, shares in Trellus Health are trading at 1.90p. This share price information is delayed by 15 minutes.
Shares in Trellus Health last closed at 1.90p and the price had moved by -70.77% over the past 365 days. In terms of relative price strength the Trellus Health share price has underperformed the FTSE All Share Index by -71.69% over the past year.
The overall consensus recommendation for Trellus Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Trellus Health does not currently pay a dividend.
Trellus Health does not currently pay a dividend.
Trellus Health does not currently pay a dividend.
To buy shares in Trellus Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1.90p, shares in Trellus Health had a market capitalisation of £3.07m.
Here are the trading details for Trellus Health:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: TRLS
Based on an overall assessment of its quality, value and momentum Trellus Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Trellus Health is 26.06p. That is 1271.79% above the last closing price of 1.90p.
Analysts covering Trellus Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trellus Health. Over the past six months, its share price has underperformed the FTSE All Share Index by -67.65%.
As of the last closing price of 1.90p, shares in Trellus Health were trading -59.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Trellus Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 1.90p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Trellus Health's directors